Human Genome’s Poison Pill Survives As GSK Eyes Coup – site.law360.com
Law360, New York (May 31, 2012, 2:24 PM ET) -- Biotech company Human Genome Sciences Inc. beat a legal challenge to the poison pill it is using to fend off a $2.6 billion hostile takeover by GlaxoSmithKline PLC on Thursday, even as reports came that GSK ...
Subscribe to LegalLaw247.Com Newsletter